Articles with public access mandates - Martin LaggingLearn more
Not available anywhere: 6
Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection
C Pedersen, Å Alsiö, M Lagging, N Langeland, M Färkkilä, ...
Journal of viral hepatitis 18 (4), 245-251, 2011
Mandates: Swedish Research Council
PRO-C3: a new and more precise collagen marker for liver fibrosis in patients with chronic hepatitis C
JF Hansen, M Juul Nielsen, K Nyström, DJ Leeming, M Lagging, ...
Scandinavian Journal of Gastroenterology 53 (1), 83-87, 2018
Mandates: Innovation Fund Denmark
Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G …
L Persson, S Longhi, J Enarsson, O Andersen, S Haghigi, S Nilsson, ...
Journal of Clinical Virology 61 (1), 107-112, 2014
Mandates: Swedish Research Council
Early quantification of HCV core antigen may help to determine the duration of therapy for chronic genotype 2 or 3 HCV infection
Å Alsiö, A Jannesson, N Langeland, C Pedersen, M Färkkilä, MR Buhl, ...
European journal of clinical microbiology & infectious diseases 31, 1631-1635, 2012
Mandates: Swedish Research Council
Cartilage oligomeric matrix protein associates with hepatic inflammation and fibrosis in hepatitis C virus infection
K Andréasson, J Waldenström, J Westin, H Norrgren, G Jönsson, ...
Journal of Hepatology 67 (3), 649-651, 2017
Mandates: US National Institutes of Health, Swedish Research Council
Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis C
S Pascarella, S Clément, MT Dill, S Conzelmann, M Lagging, G Missale, ...
Liver International 33 (1), 94-103, 2013
Mandates: Swiss National Science Foundation
Available somewhere: 46
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ...
The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022
Mandates: UK Medical Research Council
Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms
M Lagging, G Askarieh, F Negro, S Bibert, J Söderholm, J Westin, M Lindh, ...
PloS one 6 (2), e17232, 2011
Mandates: Swiss National Science Foundation, Swedish Research Council
Systemic and intrahepatic interferon‐gamma‐inducible protein 10 kDa predicts the first‐phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic …
G Askarieh, Å Alsiö, P Pugnale, F Negro, C Ferrari, AU Neumann, ...
Hepatology 51 (5), 1523-1530, 2010
Mandates: Swiss National Science Foundation, Swedish Research Council
Surveillance of wastewater revealed peaks of SARS-CoV-2 preceding those of hospitalized patients with COVID-19
F Saguti, E Magnil, L Enache, MP Churqui, A Johansson, D Lumley, ...
Water research 189, 116620, 2021
Mandates: Swedish Research Council for Environment, Agricultural Sciences and Spatial …
Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C
PDC Leutscher, M Lagging, MR Buhl, C Pedersen, G Norkrans, ...
Hepatology 52 (2), 430-435, 2010
Mandates: Swedish Research Council
IL28B polymorphisms, IP‐10 and viral load predict virological response to therapy in chronic hepatitis C
G Fattovich, L Covolo, S Bibert, G Askarieh, M Lagging, S Clément, ...
Alimentary pharmacology & therapeutics 33 (10), 1162-1172, 2011
Mandates: Swiss National Science Foundation
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C
PY Bochud, S Bibert, F Negro, B Haagmans, A Soulier, C Ferrari, ...
Journal of hepatology 55 (5), 980-988, 2011
Mandates: Swiss National Science Foundation, Swedish Research Council
Interleukin 28B Gene Variation at rs12979860 Determines Early Viral Kinetics During Treatment in Patients Carrying Genotypes 2 or 3 of Hepatitis C Virus
M Lindh, M Lagging, M Färkkilä, N Langeland, K Mørch, S Nilsson, ...
Journal of Infectious Diseases 203 (12), 1748-1752, 2011
Mandates: Swedish Research Council
Impact of IL28B-Related Single Nucleotide Polymorphisms on Liver Histopathology in Chronic Hepatitis C Genotype 2 and 3
K Rembeck, Å Alsiö, PB Christensen, M Färkkilä, N Langeland, MR Buhl, ...
PloS one 7 (1), e29370, 2012
Mandates: Swedish Research Council
Treatment of hepatitis C virus infection in adults and children: updated Swedish consensus recommendations
M Lagging, AS Duberg, R Wejstål, O Weiland, M Lindh, S Aleman, ...
Scandinavian journal of infectious diseases 44 (7), 502-521, 2012
Mandates: Swedish Research Council
Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3
K Rembeck, J Waldenström, K Hellstrand, S Nilsson, K Nyström, ...
Hepatology 59 (6), 2131-2139, 2014
Mandates: Swedish Research Council
IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV
K Falconer, G Askarieh, N Weis, K Hellstrand, A Alaeus, M Lagging, ...
Scandinavian journal of infectious diseases 42 (11-12), 896-901, 2010
Mandates: Swedish Research Council
Impact of obesity on the bioavailability of peginterferon-α2a and ribavirin and treatment outcome for chronic hepatitis C genotype 2 or 3
Å Alsiö, K Rembeck, G Askarieh, PB Christensen, M Färkkilä, ...
PloS one 7 (5), e37521, 2012
Mandates: Swedish Research Council
PNPLA 3I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection
K Rembeck, C Maglio, M Lagging, PB Christensen, M Färkkilä, ...
BMC Medical Genetics 13, 1-7, 2012
Mandates: Swedish Research Council
Publication and funding information is determined automatically by a computer program